Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection

Journal of Virology

Volumn 78, Issue 19, 2004, Pages 10460-10469

  Bain, Christine ^a   Parroche, Peggy ^a   Lavergne, Jean Pierre ^b   Duverger, Blandine ^c   Vieux, Claude ^d   Dubois, Valérie ^e   Komurian Pradel, Florence ^c   Trépo, Christian ^d   Gebuhrer, Lucette ^e   Paranhos Baccala, Glaucia ^c   Penin, François ^b   Inchauspé, Geneviève ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Tour CERVI   (France)

^d HÔTEL DIEU   (France)

^e Etablissement de Transfus Sanguine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; PEGINTERFERON; RIBAVIRIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; MEMORY CELL; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; B-LYMPHOCYTES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-10; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RIBAVIRIN; SEQUENCE HOMOLOGY; T-LYMPHOCYTES; TREATMENT OUTCOME; VIRAL CORE PROTEINS; VIREMIA;

EID: 4544321691     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.19.10460-10469.2004     Document Type: Article

References (46)

1. Bain, C., A. Fatmi, F. Zoulim, J. P. Zarski, C. Trépo, and G. Inchauspé. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524.
2. Barnes, E., G. Harcourt, D. Brown, M. Lucas, R. Phillips, G. Dusheiko, and P. Klenerman. 2002. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36:743-754.
3. Boaz, M. J., A. Waters, S. Murad, P. J. Easterbrook, and A. Vyakarnam. 2002. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169:6376-6385.
4. Boulant, S., M. Becchi, F. Penin, and J. Lavergne. 2003. Unusual multiple receding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J. Biol. Chem. 278:45785-45792.
5. Bullock, T. N., and L. C. Eisenlohr. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184:1319-1329.
6. Cramp, M. E., S. Rossol, S. Chokshi, P. Carucci, R. Williams, and N. V. Naoumov. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118:346-355.
7. a. Currier, J. R., E. G. Kuta, E. Turk, L. B. Earhart, L. Lommis-Price, S. Janetzi, G. Ferrari, D. L. Birx, and J. H. Cox. 2002. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELlSPOT assays. J. Immunol. Methods 260:157-172.
8. Day, C. L., G. Lauer, G. K. Robbins, B. McGovern, A. G. Wurcel, R. T. Gandhi, R. T. Chung, and B. D. Walker. 2002. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 76:12584-12595.
9. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
10. Doetze, A., J. Satoguina, G. Burchard, T. Rau, C. Loliger, B. Fleischer, and A. Hoerauf. 2000. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int. Immunol. 12:623-630.
11. Dolganiuc, A., K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics, Jr., P. Mandrekar, M. Zapp, and G. Szabo. 2003. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170:5615-5624.
12. Foy, E., K. Li, C. Wang, R. Sumpter, Jr., M. Ikeda, S. M. Lemon, and M. Gale, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
13. Gale, M., Jr., B. Kwieciszewski, M. Dossett, H. Nakao, and M. G. Katze. 1999. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73:6506-6516.
14. Gale, M. J., Jr, M. J. Korth, N. M. Tang, S. L. Tan, D. A. Hopkins, T. E. Dever, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural SA protein. Virology 230:217-227.
15. Gerlach, J. T., H. M. Diepolder, M.-C. Jung, N. H. Gruener, W. W. Schraut, R. Zachoval, R. Hoffmann, C. A. Schirren, T. Santantonio, and G. R. Pape. 1999. Recurrence of Hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 117:933-941.
16. Giannini, C., and C. Brechet. 2003. Hepatitis C virus biology. Cell Death Differ. 10(Suppl. 1):S27-38.
17. Godkin, A. J., H. C. Thomas, and P. J. Openshaw. 2002. Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus. J. Immunol. 169:2210-2214.
18. Hahn, C. S., Y. G. Cho, B. S. Kang, I. M. Lester, and Y. S. Hahn. 2000. The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 276:127-137.
19. Hahn, Y. S., V. L. Braciale, and T. J. Braciale. 1991. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product. J. Exp. Med. 174:733-736.
20. Kamal, S. M., J. Fehr, B. Roesler, T. Peters, and J. W. Rasenack. 2002. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123:1070-1083.
21. Kato, N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA 87:9524-9528.
22. Komurian-Pradel, F., G. Paranhos-Baccala, M. Sodoyer, P. Chevallier, B. Mandrand, V. Lotteau, and P. Andre. 2001. Quantitation of HCV RNA using real-time PCR and fluorimetry. J. Virol. Methods 95:111-119.
23. a. Komurian-Pradel, F. Hepatology, in press.
24. Li, J. S., S. P. Tong, L. Vitvitski, D. Lepot, and C. Trepo. 1991. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene 105:167-172.
25. MacDonald, A. J., M. Duffy, M. T. Brady, S. McKirnan, W. Hall, J. Hegarty, M. Curry, and K. H. G. Mills. 2002. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in Hepatitis C virus-infected persons. J. Infect. Dis. 185:720-727.
26. Marusawa, H., M. Hijikata, T. Chiba, and K. Shimotohno. 1999. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation. J. Virol. 73:4713-4720.
27. Mayrand, S. M., and W. R. Green. 1998. Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol. Today 19:551-556.
28. Mayrand, S. M., D. A. Schwarz, and W. R. Green. 1998. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus. J. Immunol. 160:39-50.
29. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-231.
30. McNeil, A. C., W. L. Shupert, C. A. Iyasere, C. W. Hallahan, J. A. Mican, R. T. Davey, Jr.,and M. Connors. 2001. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc. Natl. Acad. Sci. USA 98:13878-13883.
31. Missale, G., R. Bertoni, V. Lamonaca, A. Valli, M. Massari, C. Mori, M. G. Rumi, M. Houghton, F. Fiaccadori, and C. Ferrari. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Investig. 98:706-714.
32. Montagnier, L. 1999. Human immunodeficiency viruses (Retroviridae), p. 763-774. In A. Granoff and R. G. Webster (ed.), Encyclopedia of virology, 2nd ed., vol. 2. Academic Press, New York, N.Y.
33. Nasoff, M. S., S. L. Zebedee, G. Inchauspe, and A. M. Prince. 1991. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:5462-5466.
34. Palmer, B. E., E. Boritz, N. Blyveis, and C. C. Wilson. 2002. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4+ T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J. Virol. 76:5925-5936.
35. Prezzi, C., M. A. Casciaro, V. Francavilla, E. Schiaffella, L. Finocchi, L. V. Chircu, G. Bruno, A. Sette, S. Abrignani, and V. Barnaba. 2001. Virus-specific CDS+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur. J. Immunol. 31:894-906.
36. + T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J. Virol. 76:5062-5070.
37. Schmittel, A., U. Keilholz, S. Bauer, U. Kuhne, S. Stevanovic, E. Thiel, and C. Scheibenbogen. 2001. Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins. J. Immunol. Methods 247:17-24.
38. Seeff, L. B. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46.
39. Soguero, C., M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn. 2002. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J. Virol. 76:9345-9354.
40. Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber, and M. M. C. Lai. 1999. Inhibition of the interferon-inducible kinase PKR by HCV E2 protein. Science 285:107-110.
41. Ulsenheimer, A., J. T. Gerlach, N. H. Gruener, M. C. Jung, C. A. Schirren, W. Schraut, R. Zachoval, G. R. Pape, and H. M. Diepolder. 2003. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37:1189-1198.
42. van Eyll, O., and T. Michiels. 2002. Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J. Virol. 76:10665-10673.
43. Varaklioti, A., N. Vassilaki, U. Georgopoulou, and P. Mavromara. 2002. Alternate translation occurs within the core coding region of the hepatitis C viral genome. J. Biol. Chem. 277:17713-17721.
44. Walewski, J. L., T. R. Keller, D. D. Stump, and A. D. Branch. 2001. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7:710-721.
45. Wedemeyer, H., X. S. He, M. Nascimbeni, A. R. Davis, H. B. Greenberg, J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Rehermann. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169:3447-3458.
46. Xu, Z., J. Choi, T. S. Yen, W. Lu, A. Strohecker, S. Govindarajan, D. Chien, M. J. Selby, and J. Ou. 2001. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20:3840-3848.